Skip to main content
logo
Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
15.07
-0.93 (-5.81%)
At close: Aug 28, 2026, 4:00 PM EDT
15.36
+0.29 (1.92%)
After-hours: Aug 28, 2026, 7:53 PM EDT

Eloxx Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
60.83M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 20246.36M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Jun 30, 201675.00K--
Dec 31, 2015---
Jun 30, 201575.00K--
Dec 31, 2014---
Jun 30, 2014100.00K--
Jun 30, 2013---
Jun 30, 2012200.00K--
Jun 30, 2011---
Jun 30, 2010140.00K-135.00K-49.09%
Jun 30, 2009275.00K-181.67K-39.78%
Jun 30, 2008456.67K156.67K52.22%
Jun 30, 2007300.00K233.33K350.00%
Jun 30, 200666.67K-58.33K-46.67%
Jun 30, 2005125.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Heron Therapeutics151.18M
Xilio Therapeutics64.09M
BioStem Technologies34.59M
Apollomics8.84M
Alps Group3.74M
ImageneBio800.00K
Serina Therapeutics130.00K
INmune Bio50.00K
Revenue Rankings

ELOX News

More News